Business · 02/03/2011
FDA Clears Nystatin Powder for Sale After Review
The FDA has concluded that Nystatin Powder (100%) was not removed from the market due to safety or efficacy concerns, paving the way for potential approval of abbreviated new drug applications for the product.
Original source language: Federal Register — Health and Human ServicesOpen original release →